Profile data is unavailable for this security.
About the company
CHONGQING TAIJI INDUSTRY (GROUP) CO., LTD. is a China-based company principally engaged in the production and sales of Chinese and Western medicines. The Company is also engaged in the cultivation of medicinal herbs. The Company's products mainly include capsules, syrup, oral liquid, lyophilized series, tablets, infusion series and injections. The Company mainly conducts its business in domestic and overseas markets.
- Revenue in CNY (TTM)15.40bn
- Net income in CNY834.00m
- Incorporated1993
- Employees12.59k
- LocationChongqing Taiji Industry Group Co LtdNo.18Hengshan East Road, Yubei DistrictCHONGQING 401121ChinaCHN
- Phone+86 2 389886129
- Fax+86 2 389887399
- Websitehttp://www.taiji.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dizal Jiangsu Pharmaceutical Co Ltd | 172.61m | -1.09bn | 17.49bn | 581.00 | -- | 25.11 | -- | 101.33 | -2.67 | -2.67 | 0.422 | 1.68 | 0.1008 | 0.3215 | 6.78 | 297,086.40 | -63.79 | -46.02 | -82.62 | -52.99 | 96.41 | 57.53 | -632.90 | -2,081.54 | 1.74 | -- | 0.4557 | -- | -- | 18.29 | -50.50 | -- | 21.35 | -- |
| Tonghua Dongbao Pharmaceutical Co Ltd | 3.00bn | 1.13bn | 18.17bn | 3.20k | 16.14 | 2.46 | -- | 6.05 | 0.5682 | 0.5682 | 1.51 | 3.73 | 0.403 | 0.8622 | 4.57 | 939,125.30 | 15.20 | 18.68 | 15.84 | 19.68 | 79.89 | 78.73 | 37.71 | 39.20 | 5.04 | -- | 0.03 | 41.73 | 10.69 | 2.69 | -26.17 | 6.85 | -14.75 | 4.56 |
| Sinocelltech Group Ltd | 2.17bn | -168.81m | 19.37bn | 2.33k | -- | -- | -- | 8.92 | -0.3791 | -0.3791 | 4.88 | -1.16 | 0.761 | 0.3743 | 6.86 | 930,592.90 | -5.93 | -40.17 | -15.48 | -74.63 | 96.35 | 95.42 | -7.79 | -108.20 | 0.4649 | 3.33 | 1.23 | -- | 84.46 | 264.19 | 23.70 | -- | 37.54 | -- |
| Tasly Pharmaceutical Group Co Ltd | 8.64bn | 1.10bn | 20.68bn | 9.22k | 18.85 | 1.63 | -- | 2.39 | 0.7342 | 0.7342 | 5.77 | 8.47 | 0.4899 | 1.72 | 10.80 | 937,046.80 | 5.93 | 5.47 | 7.21 | 7.25 | 65.67 | 48.42 | 12.11 | 8.94 | 2.73 | 5.91 | 0.2083 | 50.99 | 0.4236 | -13.57 | 505.34 | -7.07 | -3.03 | 1.92 |
| Chongqing Taiji Industry Group Co Ltd | 15.40bn | 834.00m | 20.70bn | 12.59k | 24.82 | 5.35 | -- | 1.34 | 1.50 | 1.50 | 27.66 | 6.95 | 1.03 | 3.15 | 5.84 | 1,223,535.00 | 5.77 | 0.7814 | 17.83 | 2.35 | 46.14 | 44.03 | 5.62 | 0.8498 | 0.5315 | 6.12 | 0.5393 | 25.76 | 10.58 | 7.88 | 131.99 | 63.55 | 3.86 | 24.57 |
| Nanjing King-Frind Bchmcl Phrmctcl C Ltd | 3.63bn | -344.58m | 20.85bn | 1.45k | -- | 3.48 | -- | 5.75 | -0.2727 | -0.2727 | 2.30 | 3.71 | 0.3561 | 0.4354 | 3.35 | 2,500,466.00 | -3.38 | 8.97 | -4.83 | 13.15 | 43.57 | 45.59 | -9.50 | 20.12 | 1.15 | -- | 0.3129 | 26.33 | 5.89 | 18.25 | -117.37 | -- | 38.32 | 13.75 |
| Xiamen Amoytop Biotech Co Ltd | 2.23bn | 600.08m | 21.95bn | 1.96k | 36.57 | 10.94 | -- | 9.86 | 1.48 | 1.48 | 5.47 | 4.93 | 1.04 | 0.8541 | 6.70 | 1,135,877.00 | 28.09 | 17.96 | 32.72 | 21.02 | 93.17 | 90.48 | 26.95 | 19.17 | 3.22 | -- | 0.0037 | 26.95 | 37.55 | 36.19 | 93.52 | 103.28 | 81.61 | -- |
| China Resources Dubl-Crne Phrmctl Co Ltd | 10.32bn | 1.38bn | 22.16bn | 12.27k | 15.88 | 1.90 | -- | 2.15 | 1.34 | 1.34 | 10.07 | 11.24 | 0.6781 | 2.85 | 5.82 | 841,054.60 | 8.87 | 8.58 | 11.67 | 11.21 | 54.25 | 58.19 | 13.08 | 11.98 | 2.15 | -- | 0.0249 | 35.91 | 6.20 | 4.44 | 12.96 | 6.60 | 21.46 | -1.63 |
| Joincare Pharmaceutical Group Ind. Co. | 16.43bn | 1.42bn | 23.30bn | 14.37k | 16.26 | 1.64 | -- | 1.42 | 0.7676 | 0.7676 | 8.86 | 7.63 | 0.4522 | 2.36 | 5.57 | 1,143,551.00 | 7.98 | 8.46 | 16.51 | 18.84 | 61.23 | 62.72 | 17.64 | 17.00 | 2.11 | -- | 0.2247 | 28.86 | -2.90 | 8.24 | -3.99 | 15.58 | 11.53 | 2.38 |
Data as of Jun 07 2024. Currency figures normalised to Chongqing Taiji Industry Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
17.72%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Zhong Ou Asset Management Co., Ltdas of 30 Sep 2023 | 18.62m | 3.34% |
| Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 31 Dec 2023 | 14.68m | 2.64% |
| GF Fund Management Co., Ltd.as of 30 Sep 2023 | 8.96m | 1.61% |
| China Asset Management Co., Ltd.as of 29 Feb 2024 | 8.77m | 1.57% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 8.47m | 1.52% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2023 | 8.20m | 1.47% |
| Minsheng Royal Fund Management Co., Ltd.as of 31 Dec 2023 | 8.11m | 1.46% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 7.88m | 1.41% |
| Huashang Fund Management Co., Ltd.as of 31 Dec 2023 | 7.83m | 1.41% |
| CCB Principal Asset Management Co., Ltd.as of 31 Dec 2023 | 7.17m | 1.29% |
More ▼
Data from 31 Dec 2023 - 06 Jun 2024Source: FactSet Research Systems Inc.
